Cargando…

Evolutionary ecology of Chagas disease; what do we know and what do we need?

The aetiological agent of Chagas disease, Trypanosoma cruzi, is a key human pathogen afflicting most populations of Latin America. This vectorborne parasite is transmitted by haematophageous triatomines, whose control by large‐scale insecticide spraying has been the main strategy to limit the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores‐Ferrer, Alheli, Marcou, Olivier, Waleckx, Etienne, Dumonteil, Eric, Gourbière, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891055/
https://www.ncbi.nlm.nih.gov/pubmed/29636800
http://dx.doi.org/10.1111/eva.12582
_version_ 1783312957627695104
author Flores‐Ferrer, Alheli
Marcou, Olivier
Waleckx, Etienne
Dumonteil, Eric
Gourbière, Sébastien
author_facet Flores‐Ferrer, Alheli
Marcou, Olivier
Waleckx, Etienne
Dumonteil, Eric
Gourbière, Sébastien
author_sort Flores‐Ferrer, Alheli
collection PubMed
description The aetiological agent of Chagas disease, Trypanosoma cruzi, is a key human pathogen afflicting most populations of Latin America. This vectorborne parasite is transmitted by haematophageous triatomines, whose control by large‐scale insecticide spraying has been the main strategy to limit the impact of the disease for over 25 years. While those international initiatives have been successful in highly endemic areas, this systematic approach is now challenged by the emergence of insecticide resistance and by its low efficacy in controlling species that are only partially adapted to human habitat. In this contribution, we review evidences that Chagas disease control shall now be entering a second stage that will rely on a better understanding of triatomines adaptive potential, which requires promoting microevolutionary studies and –omic approaches. Concomitantly, we show that our knowledge of the determinants of the evolution of T. cruzi high diversity and low virulence remains too limiting to design evolution‐proof strategies, while such attributes may be part of the future of Chagas disease control after the 2020 WHO's target of regional elimination of intradomiciliary transmission has been reached. We should then aim at developing a theory of T. cruzi virulence evolution that we anticipate to provide an interesting enrichment of the general theory according to the specificities of transmission of this very generalist stercorarian trypanosome. We stress that many ecological data required to better understand selective pressures acting on vector and parasite populations are already available as they have been meticulously accumulated in the last century of field research. Although more specific information will surely be needed, an effective research strategy would be to integrate data into the conceptual and theoretical framework of evolutionary ecology and life‐history evolution that provide the quantitative backgrounds necessary to understand and possibly anticipate adaptive responses to public health interventions.
format Online
Article
Text
id pubmed-5891055
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58910552018-04-10 Evolutionary ecology of Chagas disease; what do we know and what do we need? Flores‐Ferrer, Alheli Marcou, Olivier Waleckx, Etienne Dumonteil, Eric Gourbière, Sébastien Evol Appl Review and Syntheses The aetiological agent of Chagas disease, Trypanosoma cruzi, is a key human pathogen afflicting most populations of Latin America. This vectorborne parasite is transmitted by haematophageous triatomines, whose control by large‐scale insecticide spraying has been the main strategy to limit the impact of the disease for over 25 years. While those international initiatives have been successful in highly endemic areas, this systematic approach is now challenged by the emergence of insecticide resistance and by its low efficacy in controlling species that are only partially adapted to human habitat. In this contribution, we review evidences that Chagas disease control shall now be entering a second stage that will rely on a better understanding of triatomines adaptive potential, which requires promoting microevolutionary studies and –omic approaches. Concomitantly, we show that our knowledge of the determinants of the evolution of T. cruzi high diversity and low virulence remains too limiting to design evolution‐proof strategies, while such attributes may be part of the future of Chagas disease control after the 2020 WHO's target of regional elimination of intradomiciliary transmission has been reached. We should then aim at developing a theory of T. cruzi virulence evolution that we anticipate to provide an interesting enrichment of the general theory according to the specificities of transmission of this very generalist stercorarian trypanosome. We stress that many ecological data required to better understand selective pressures acting on vector and parasite populations are already available as they have been meticulously accumulated in the last century of field research. Although more specific information will surely be needed, an effective research strategy would be to integrate data into the conceptual and theoretical framework of evolutionary ecology and life‐history evolution that provide the quantitative backgrounds necessary to understand and possibly anticipate adaptive responses to public health interventions. John Wiley and Sons Inc. 2017-12-25 /pmc/articles/PMC5891055/ /pubmed/29636800 http://dx.doi.org/10.1111/eva.12582 Text en © 2017 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review and Syntheses
Flores‐Ferrer, Alheli
Marcou, Olivier
Waleckx, Etienne
Dumonteil, Eric
Gourbière, Sébastien
Evolutionary ecology of Chagas disease; what do we know and what do we need?
title Evolutionary ecology of Chagas disease; what do we know and what do we need?
title_full Evolutionary ecology of Chagas disease; what do we know and what do we need?
title_fullStr Evolutionary ecology of Chagas disease; what do we know and what do we need?
title_full_unstemmed Evolutionary ecology of Chagas disease; what do we know and what do we need?
title_short Evolutionary ecology of Chagas disease; what do we know and what do we need?
title_sort evolutionary ecology of chagas disease; what do we know and what do we need?
topic Review and Syntheses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891055/
https://www.ncbi.nlm.nih.gov/pubmed/29636800
http://dx.doi.org/10.1111/eva.12582
work_keys_str_mv AT floresferreralheli evolutionaryecologyofchagasdiseasewhatdoweknowandwhatdoweneed
AT marcouolivier evolutionaryecologyofchagasdiseasewhatdoweknowandwhatdoweneed
AT waleckxetienne evolutionaryecologyofchagasdiseasewhatdoweknowandwhatdoweneed
AT dumonteileric evolutionaryecologyofchagasdiseasewhatdoweknowandwhatdoweneed
AT gourbieresebastien evolutionaryecologyofchagasdiseasewhatdoweknowandwhatdoweneed